Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • JQL
    Member
    • Apr 2011
    • 83

    microRNA sequencing depth

    Hi,

    Sorry if this has already been discussed before. I wonder how many samples one can pool into one Illumina hiseq2000 lane for miR seq? I was told each lane can generate 180MM SR50 reads.

    thanks in advance.
  • mbhudson
    Junior Member
    • Aug 2015
    • 3

    #2
    I have been trying to figure out the same thing. Here is a good paper http://www.biomedcentral.com/1471-2164/15/423

    From the paper "One of the common questions in miRNA-Seq design is how deep miRNA sequencing needs to be. To provide some guidance to investigators, we conducted a simulation study with a miRNA-Seq sample with 25 million of reads. The experiment started from the complete dataset and then randomly drew 0.5, 1, and 2 to 24 with 2 million increments. At the full data, 1,121 miRNAs were detectable with at least 2 reads and these miRNAs were binned into 5 levels of expression. Almost all miRNAs with expression greater than 15 reads (58% of expressed miRNAs) were detectable at 6–8 million of sequence reads. With 12–18 million of reads, 78% of all expressed miRNAs could be detected. Although further increase of sequence depth could capture very low expressed miRNAs, their biological significance can be questionable thus a sequence depth of at least 10 million reads per sample could get a reasonable capture for expressed miRNAs (Figure 5) assuming the miRNA-Seq library mostly consists of miRNAs."

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 11:41 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...